NIAID Funding News, May 17, 2017

May 17, 2017 NIAID Funding News

Read this full issue online at https://www.niaid.nih.gov/grants-contracts/niaid-funding-news-may-17-2017

Feature Articles 

Investigators: Have You Checked Your ClinicalTrials.gov Records Lately?

NIH updated its policies for clinical trial registration and results reporting. How the changes apply to you depends on a few factors, such as the date of your competing application submission and your trial’s primary completion date.

Opportunities and Resources

Funding Opportunity Focuses on Innovative Vaccine Research

The opportunity will support high-risk, high-impact, early discovery research on vaccine approaches to prevent the acquiring of or ongoing infection by HIV.

Four NIH Director's Award Opportunities for High-Risk Research

Scientists who can propose highly innovative approaches to major challenges in biomedical research should consider four reissued NIH Director's Award funding opportunity announcements.

In The News

NIH Unveils Plans for Grant Support Index

Earlier this month, NIH announced the Grant Support Index, a new policy that will limit the number of grants that any single principal investigator can have at one time.

News Briefs

• Provide Feedback on Age Groupings as an Inclusion Criterion
• Use FORMS-E Application Forms and Instructions for January 25, 2018 Due Dates
• NIH Posts Opportunities for Regenerative Medicine Innovation Projects Funding
• Disease Agent Modeling R01 Reissued To Shift Locus of Review
• NIAID Caregiver Supplements Program To Continue

Advice Corner

Find Your Score and More in the Summary Statement

It’s probably safe to say that after your grant application is peer reviewed, the information you’re most anxious to get is the overall impact/priority score.

Reader Questions

• If I receive a just-in-time notification, does that mean I'll get an award?
• When does NIH consider my application to be investigator-initiated research?

New Funding Opportunities

• PAR-17-267, Modeling of Infectious Disease Agent Study Research Projects (R01)
• PA-17-278, HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R21)
• PA-17-279, HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R01)
• PA-17-280, In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R01)
• PA-17-281, In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R21)
• PA-17-282, Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R21)
• PA-17-283, Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R01)
• RFP-NIAID-DMID-NIHAI2017087, Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases

See other announcements at Opportunities & Announcements.

Send suggestions or comments to deaweb@niaid.nih.gov.